Obesity Drug Reimbursement in France: France is set to become the first EU country to reimburse anti-obesity weight-loss drugs (including Wegovy and Mounjaro) for severely obese patients from mid-June, a major shift for access and affordability. Heatwave Health Risks: Europe’s unusually early May heatwave is already stressing public health systems, with France and the UK reporting heat-related deaths and calls for tighter vigilance during outdoor activity and heat alerts. Cancer Care Breakthrough: Greywolf Therapeutics reported early clinical results for an oral ERAP1 inhibitor (GRWD5769) with cemiplimab, showing objective response rates across multiple hard-to-treat cancer settings. Pharma Deal Watch: Servier is expanding into neuromuscular disorders by acquiring Edgewise Therapeutics’ sevasemten program, targeting rare muscular dystrophies. Ebola Update (DRC/Uganda): Africa CDC says suspected Ebola cases are still high (over 1,100 under investigation) as response plans roll out amid concerns about reliance on external funding. Digital Safety for Youth: Malaysia introduced a ban on social media accounts for under-16s with age verification and platform fines, adding pressure for similar rules across Europe. Climate + Cities: A study links vehicle traffic to extra urban heat in city centers, showing that exhaust and road friction can worsen heat exposure beyond buildings and air conditioning.